Companion Diagnostics & Biomarkers – Paving the way for Personalized Medicine

Companion Diagnostics & Biomarkers – Paving the way for Personalized Medicine

Prior to and only enhanced by the pandemic, in vitro analysis of biological specimens like tissue samples or blood amongst others plays a huge role in guiding accurate diagnosis & subsequent therapy. When used in tandem with a specific therapeutic drug or medicine and relying on the presence or absence of a predictive biomarker, such IVD are known as Companion Diagnostics (CDx). A companion diagnostic is essentially a medical device while helps differentiate patients between responders & non responders with reference to a certain drug or therapy. For example, a…

Read More

Global Food Safety Testing – A Step Towards a Healthier Tomorrow

Global Food Safety Testing – A Step Towards a Healthier Tomorrow

The pandemic served up some stark reminders of our visibly fragile mortality. Over the course of two years, Covid-19 ravaged humanity and yet it did leave behind silver linings.Epidemic & global pandemic preparedness increased tenfold. Technological innovations were integrated sooner & the healthcare ecosystem worked in overdrive, accelerating its development of crucial vaccines. More importantly it instilled in the majority of us, the importance of the quality of food we consume and how it subsequently fuels our immune system. Few of us can now deny the significance of maintaining a…

Read More

Developments & Challenges within the Single Cell Analysis Ecosystem

Developments & Challenges within the Single Cell Analysis Ecosystem

With just over a month till the MarketsandMarkets BioPharma Series kicks off in Boston on the 23rd & 24th of June 2022, we believed it would be apt to unveil a glimpse of the enriching insights our esteemed speakers shall be bringing to the tri-conference event. On the eve of our 3rd Annual MarketsandMarkets Single-Cell Analysis Conference, we sat down with Jun Wang, Associate Professor (Department of Biomedical Engineering) at Stony Brook University, New York who is also a keynote speaker at the conference. As part of the conversation, we…

Read More

Electric Vehicles Infrastructure – Growth & Its Challenges

Electric Vehicles Infrastructure – Growth & Its Challenges

Post the turn of the century, unchecked plundering of our limited fossil fuels & natural gas reserves has driven humanity to the fragile precipice it stands on today. Heatwaves have gone from freak phenomena to a regular occurrence around the globe. AQI’s of major cities & international business hubs continue to decline in quality as the amount of air pollution maintains its upward arc. Innovations & technological developments clubbed with increasing population has naturally paved the way for more & more vehicles on road and as oil reserves begin to…

Read More

Immuno-Oncology : The Latest Frontier in Cancer Therapy

Immuno-Oncology : The Latest Frontier in Cancer Therapy

For as long as medicine has existed, cancers have ravaged humanity. The search for an eventual cure has been a tremendous & tireless pursuit, selflessly undertaken by doctors, researchers, scientists & the entire healthcare community.  With each passing year and the availability of sophisticated technologies, their efforts continue to go from strength to strength, expanding our means to adequately cope, manage and possibly rebuff the disease which has so often reminded us of our mortality. Up until recently, Chemotherapy, Surgeries, Radiation & Targeted Drug therapies had been the go-to for…

Read More

Lucrative Opportunity in Lab Automation

Lucrative Opportunity in Lab Automation

The global lab automation market size is projected to grow from an estimated USD 4.3 billion in 2020 to USD 5.5 billion by 2025, at a CAGR of 5.2% during the forecast period. Market growth is driven largely by factors, such as increasing expenditure on research & development by pharmaceutical companies, and Strict regulation for healthcare. The improving healthcare infrastructure across emerging countries, and growth of the pharmaceutical and biotechnology industries are expected to present avenues of growth for market players. Emerging markets are expected to offer significant growth opportunities…

Read More

BIOSIMILARS: Origins & The Path Forward

BIOSIMILARS: Origins & The Path Forward

Almost 7 years removed from the first FDA approved Biosimilar (Zarxio) in 2015, the US market for Biosimilars is projected to be highly beneficial over the next decade, for both pharmaceutical companies as well as patients, with RAND Corporation projecting estimated savings of over $54 Billion during this period. To truly comprehend such forecasts, a deeper understanding of what constitutes a ‘Biosimilar Drug’ is required. Essentially, the structure of a biosimilar is based on a pre-existing, approved drug known as a Biologic & possesses no significant clinical difference in safety,…

Read More

AI – The Future at our Doorstep

AI – The Future at our Doorstep

Artificial Intelligence has progressively transitioned from a futuristic technology expected to be decades away, to one whose usage & integration into our daily lives is growing by the minute.From quantum computing to medical diagnostics and the more prevalent trend of autonomous vehicles, AI has well and truly arrived & is here to stay. With a large stream of information flowing across the endless digital space, any effort to understand the structure, capabilities & potential benefits or disadvantages of AI is a mammoth task for a vast majority of the world….

Read More

Catch up with Matt Davis’ talk on “Neoantigen Targeted Cancer Immunotherapy in the Clinic” at Advance Genetic Sequencing Virtual Conference 2021

Catch up with Matt Davis’ talk on “Neoantigen Targeted Cancer Immunotherapy in the Clinic” at Advance Genetic Sequencing Virtual Conference 2021

Matt Davis PhD joined Gritstone Oncology (NASDAQ: GRTS) in 2015 and is currently the Director of Molecular Biology and Sequencing responsible for various neo-antigen discovery and translational genomics efforts.  Prior to Gritstone, Dr. Davis conducted post-doctoral research at Warp Drive Bio in the discovery biology group.  He holds a PhD in Genetics from Yale with thesis research under the supervision of Dr. Joseph Schlessinger and previous to his graduate work he conducted cancer genomics research at Dana Farber Cancer Institute and the Broad Institute. Marketsandmarkets took this opportunity to talk…

Read More

Ning Wang talks about “Single cell sequencing: a powerful approach to profile tumor microenvironment” at Advance Genetic Sequencing Virtual Conference 2021

Ning Wang talks about “Single cell sequencing: a powerful approach to profile tumor microenvironment” at Advance Genetic Sequencing Virtual Conference 2021

Ning is a bioinformatics scientist at Arcus Biosciences, where he is responsible for drug discovery, target identification, and indication prioritization in multiple immune-oncology drug programs. Notably, Ning pioneered the 3D organoids based drug response prediction technology, which largely facilitated cancer model selection. During his PhD, he studied with Professor Alexander Hoffmann at UCLA, where he built up computational framework to identify synergy between key immune response signaling pathways in macrophage. Ning holds a PhD in Bioinformatics from UCLA. Marketsandmarkets took this opportunity to pick his brains on the newfound developments…

Read More